Cited by 134SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesSARS-CoV-2 detection and testing

SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021

Open access
Murhekar, Manoj V., Bhatnagar, Tarun, Thangaraj, Jeromie Wesley Vivian, Saravanakumar, V., Kumar, Muthusamy Santhosh, Selvaraju, Sriram, Rade, Kiran, Kumar, C.P. Girish +128 more·2021·International Journal of Infectious Diseases

Abstract

BACKGROUND: Earlier serosurveys in India revealed seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) of 0.73% in May-June 2020 and 7.1% in August-September 2020. A third serosurvey was conducted between December 2020 and January 2021 to estimate the seroprevalence of SARS-CoV-2 infection among the general population and healthcare workers (HCWs) in India. METHODS: The third serosurvey was conducted in the same 70 districts as the first and second serosurveys. For each district, at least 400 individuals aged ≥10 years from the general population and 100 HCWs from subdistrict-level health facilities were enrolled. Serum samples from the general population were tested for the presence of immunoglobulin G (IgG) antibodies against the nucleocapsid (N) and spike (S1-RBD) proteins of SARS-CoV-2, whereas serum samples from HCWs were tested for anti-S1-RBD. Weighted seroprevalence adjusted for assay characteristics was estimated. RESULTS: Of the 28,598 serum samples from the general population, 4585 (16%) had IgG antibodies against the N protein, 6647 (23.2%) had IgG antibodies against the S1-RBD protein, and 7436 (26%) had IgG antibodies against either the N protein or the S1-RBD protein. Weighted and assay-characteristic-adjusted seroprevalence against either of the antibodies was 24.1% [95% confidence interval (CI) 23.0-25.3%]. Among 7385 HCWs, the seroprevalence of anti-S1-RBD IgG antibodies was 25.6% (95% CI 23.5-27.8%). CONCLUSIONS: Nearly one in four individuals aged ≥10 years from the general population as well as HCWs in India had been exposed to SARS-CoV-2 by December 2020.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijid.2021.05.040

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reported COVID-19 cases generally capture a small fraction of total infections, and deaths in these systems are undercounts.

    “it is widely recognized that reported cases generally capture a small fraction of total infections, and that deaths in these systems are undercounts [8–10].”
  • The third national serosurvey, carried out during December 2020-January 2021, estimated national seroprevalence of 24.1%, corresponding to approximately 325 million infections nationwide.

    “The third national serosurvey carried out during December 2020–January 2021 estimated seroprevalence of 24.1% nationally, corresponding to approximately 325M infections nationwide [10].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Murhekar, M. V., Bhatnagar, T., Thangaraj, J. W. V., Saravanakumar, V., Kumar, M. S., Selvaraju, S., Rade, K., Kumar, C. P. G., Sabarinathan, R., Turuk, A., Asthana, S., Balachandar, R., Bangar, S. D., Bansal, A. K., Chopra, V., Das, D., Deb, A. K., Devi, K. R., Dhikav, V., Dwivedi, G. R., Khan, S. M. S., Kumar, M. S., Laxmaiah, A., Madhukar, M., Mahapatra, A., Rangaraju, C., Turuk, J., Yadav, R., Andhalkar, R., Arunraj, K., Bharadwaj, D. K., Bharti, P., Bhattacharya, D., Bhat, J., Chahal, A. S., Chakraborty, D., Chaudhury, A., Deval, H., Dhatrak, S., Dayal, R., Elantamilan, D., Giridharan, P., Haq, I., Hudda, R. K., Jagjeevan, B., Kalliath, A., Kanungo, S., Krishnan, N. N., Kshatri, J. S., Kumar, A., Kumar, N., Kumar, V. G. V., Lakshmi, G. G. J. N., Mehta, G., Mishra, N. K., Mitra, A., Nagbhushanam, K., Nimmathota, A., Nirmala, A. R., Pandey, A. K., Prasad, G. V., Qurieshi, M. A., Reddy, S. D., Robinson, A., Sahay, S., Saxena, R., Sekar, K., Shukla, V. K., Singh, H. B., Singh, P. K., Singh, P., Singh, R., Srinivasan, N., Varma, D. S., Viramgami, A., Wilson, V. C., Yadav, S., Yadav, S., Zaman, K., Chakrabarti, A., Das, A., Dhaliwal, R. S., Dutta, S., Kant, R., Khan, A. M., Narain, K., Narasimhaiah, S., Padmapriyadarshini, C., Pandey, K., Pati, S., Patil, S., Rajkumar, H., Ramarao, T., Sharma, Y. K., Singh, S., Panda, S., Reddy, D. C. S., Bhargava, B., Anand, T., Babu, G. R., Chauhan, H., Dikid, T., Gangakhedkar, R. R., Kant, S., Kulkarni, S., Muliyil, J. P., Pandey, R. M., Sarkar, S., Shah, N., Shrivastava, A., Singh, S. K., Zodpe, S., Hindupur, A., Asish, P. R., Chellakumar, M., Chokkalingam, D., Dasgupta, S., Gowtham, M. M. E., Jose, A., Kalaiyarasi, K., Karthik, N. N., Karunakaran, T., Kiruthika, G., Dinesh Kumar, H., Sarath Kumar, S., Sarath Kumar, M. P., Michaelraj, E., Pradhan, J., Arun Prasath, E. B., Gladys Angelin Rachel, D., Rani, S., Rozario, A., Sivakumar, R., Gnana Soundari, P., Sujeetha, K., & Vinod, A.
Affiliations
  • National Institute of Epidemiology (IN)
  • Government of Kerala (IN)
  • National Institute of Research in Tuberculosis (IN)
  • World Health Organization - India (IN)
  • Indian Council of Medical Research (IN)
  • National Institute of Cancer Prevention and Research (IN)
  • National Institute of Occupational Health (IN)
  • National AIDS Research Institute (IN)
  • National JALMA Institute for Leprosy & Other Mycobacterial Diseases (IN)
  • Regional Medical Research Center (IN)
  • National Institute of Cholera and Enteric Diseases (IN)
  • Regional Medical Research Centre (IN)
  • National Institute for Implementation Research on Non-Communicable Diseases (IN)
  • National Institute of Nutrition (IN)
  • Rajendra Memorial National Institute of Health Research (IN)
  • National Tuberculosis Institute (IN)
  • Government Medical College (IN)
  • Government of Andhra Pradesh (IN)
Corresponding author
Murhekar, Manoj V.
Venue
International Journal of Infectious Diseases
Publisher
Elsevier BV
Published
2021-07
Volume
108
Pages
145-155
ISSN
1201-9712 (ISSN-L)
OpenAlex
W3163246137
Cited by
134
References
21
Citations by year
2026: 5 · 2025: 10 · 2024: 23 · 2023: 19 · 2022: 52 · 2021: 25
FWCI
9.41
Type
journal article
Language
en
Open access
Locations
  • International Journal of Infectious Diseases (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Indian Council of Medical Research
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords
SARS-CoV-2, COVID-19 pandemic, seroprevalence, IgG, healthcare workers, general population, nucleocapsid protein, India, serological survey, SARS-CoV-2 exposure
MeSH terms
COVID-19, SARS-CoV-2, Antibodies, Viral, Health Personnel, Humans, Seroepidemiologic Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review